Clinical Trials Browser

Breast Neoplasms, Hepatitis C

NCT02366286 2026-04-24

Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants

Completed

892 enrolled

Gastrointestinal

Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular

NCT01280825 2026-03-04

The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing

Recruiting

1,200 enrolled

Autoimmune Diseases, Blood Coagulation Disorders, Heart Diseases, Hepatitis C, Inflammatory Bowel Diseases

NCT02422875 2025-09-30

Comparative Autoantibody and Immunologic Cell Marker Study

Enrolling by invitation

2,500 enrolled

Undifferentiated Connective Tissue Diseases, Immunoglobulin G4-Related Disease, Acquired Immunodeficiency Syndrome, Arthritis, Arthritis, Juvenile, Arthritis, Rheumatoid, Autoimmune Diseases, Communicable Diseases, Graft vs Host Disease, Hepatitis C, Lupus Erythematosus, Systemic, Myositis, Sjogren's Syndrome, Purpura, Thrombocytopenic, Idiopathic, Sepsis, Epstein-Barr Virus Infections, Guillain-Barre Syndrome, Scleroderma, Diffuse, Autoimmune Lymphoproliferative Syndrome

Clinical Trials

Mammo'C

Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants

The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing

Comparative Autoantibody and Immunologic Cell Marker Study

Liver Disease and Other Systemic Diseases

VERYMARKERS

Utilization of MAsS in Patients Undergoing LT for HCC

Ablation of Hepatocellular Carcinoma: a Nationwide Study

Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population

CARES-HCV: Promoting Screening Uptake Among Diverse Baby Boomers

ECHAPS

Possible Differences in HCC Course Depending on DAA Treatment

Effect of DAAs on Behavior of HCC in HCV Patients

HEPCASUS

Association of Hepatitis C Virus With Breast Cancer

Hepatitis C Virus Detection in Oral Squamous Cell Carcinoma

A2ALL-2

Incidence of de Novo Hepatocellular Carcinoma After Antiviral Agents for HCV.

A2ALL-1

RECAR

Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma

Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease

Viral Load Changes in Lymphoma Patients With HCV Infection After Chemotherapy

Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients

ROLFH

Association Between Hepatitis C Infection and Renal Cell Carcinoma

Application of the Stem Cell Therapy in the End Stage Liver Disease and Assessment Its Consequences in the Quality of Live Style as Well as Development of HCC.

Genetic Analysis of Liver Cancer

Comparison of Selenium Levels in HCV- Infected Patients at Different Stages of Disease

PICTURE

Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by SELDI